Regis College is pleased to announce Eva Kenneally, MBA, has been appointed to its board of trustees.
Kenneally is an accomplished executive with more than 20 years of experience managing go-to-market strategy while optimizing commercial operations and business decisions infrastructure. She serves as Head of Strategy and Operations at Ipsen Biopharmaceuticals in Cambridge, MA, where she is responsible for the design and execution of the rare disease business unit strategy. Prior to this she served for five years as Vice President of Marketing at Alkermes, Inc. in Waltham; and in vice president roles at Vertex Pharmaceuticals.
“With a track record of delivering results through strategic thinking, operational management and team building, as well as her passion for making a difference, I am thrilled Eva will be joining the Regis Board and look forward to her contributions to the strategic direction of the university,” said Regis College President Antoinette M. Hays, PhD, RN. “Board members such as Eva possess a wealth of wisdom and knowledge to empower Regis students to become agents of change for a better world.”
“I am pleased to be joining the Board of Trustees at Regis College and excited to support advancement of leadership in health science education at such a renowned nursing and health sciences university,” said Kenneally.
Kenneally received a master of business administration from the Olin Graduate School of Business at Babson College and bachelor’s in market research and statistics from Charles University in Prague, Czech Republic. She lives in Boston with her husband of over 30 years and their two children.
